The ERα-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer.
Cell Commun Signal
; 20(1): 178, 2022 11 14.
Article
in En
| MEDLINE
| ID: mdl-36376959
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Estrogen Receptor alpha
/
Prostatic Neoplasms, Castration-Resistant
Limits:
Humans
/
Male
Language:
En
Journal:
Cell Commun Signal
Year:
2022
Type:
Article
Affiliation country:
China